Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose dexamethasone for pain reduction after VATS lobectomy or segmentectomy in high-pain responders
2025-520891-25-00Phase 2Authorised
- Sponsor
- Rigshospitalet
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of HiDex in acute postoperative pain (2 arms), sponsored by Rigshospitalet. Primary endpoint: Pain when coughing on postoperative day 1 morning. Planned start Aug 2025; status: authorised.
02
Drugs
HiDex
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on 2025-520891-25-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-520891-25-00.